Trump Pressures Bank of America and JPMorgan to Cease Alleged Discrimination Against Conservatives Memory Industry Cycle Raises Caution Amid AIDriven Rally Investor Warns Japan Core Inflation Slips to Over FourYear Low Dampening Expectations for BOJ Rate Hike Turkish Political Turmoil Riot Police Raid Opposition Headquarters Amid Leadership Dispute Amazon Reports RecordBreaking Thanksgiving Holiday Week with Surge in Sales and Items Sold Navigating Marriage Finances Exploring Combined and Separate Approaches SNYR Q1 2026 Earnings Stock Rises Despite Massive EPS Miss Amid Operational Challenges Ducommun DCO Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher SION Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline Stock Edges Higher Main Street Capital Corporation MAIN Q1 2026 Earnings EPS Miss Weighs on Shares SKE Q1 2026 Earnings Significant EPS Miss Amid Exploration Stage Operations Modiv Industrial Inc Class C MDV Q1 2026 Earnings Steep EPS Miss and Stock Decline Highlight Challenging Quarter JDcom Edges Higher as Resistance Test Looms Church Dwight CHD Holds Steady Near Key Support Amid Defensive Rotation Sphere Entertainment Co SPHR Advances 369 as Shares Test Key Resistance Level ConnectOne Bancorp CNOB Gains Ground as Buyers Return Near Support Erie Indemnity ERIE Shows Modest Decline as Price Consolidates Near Key Support BKV Corporation Edges Lower After Recent Rally Tests Key Support Levels Calisa Acquisition Corp Units ALISU Hover Near Support as Price Remains Flat PennantPark Floating Rate Capital Ltd PFLT Shows Modest Advance Amid Narrow Trading Range Julong Holding Limited JLHL Tumbles Over 11 as Selling Pressure Intensifies Bloomia Holdings Inc TULP Drops 831 as Selling Pressure Intensifies Near Key Support Centerra Gold CGAU Surges 571 as Gold Rally Lifts Mining Stocks Wall Streets Favorite Stocks vs Overlooked Opportunities A Balanced Market View New Concept Energy Inc GBR Q3 2023 Earnings Positive EPS Reported Amidst Limited Disclosure Stock Declines Addex Therapeutics ADXN Slips 229 as Stock Hovers Near Key Support